AbbVie, Teva Can't Make Niaspan Buyers Give Up Sales Data

By Lance Duroni (July 10, 2015, 5:26 PM EDT) -- A Pennsylvania federal judge on Thursday denied AbbVie Inc. and Teva Pharmaceuticals Industries Ltd. access to financial information from pharmacy wholesalers who are pursuing an antitrust class action against the drugmakers over an alleged pay-for-delay scheme involving generic versions of the cholesterol drug Niaspan....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!